|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| REVENUES: | |||||
| Net sales | |||||
| Other revenue | |||||
| Total revenue | |||||
| COSTS AND EXPENSES: | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Costs related to debt amendments | |||||
| Depreciation and amortization | |||||
| Impairment charges - long-lived assets | |||||
| Other income - net | |||||
| Loss on extinguishment of debt | |||||
| Interest income | |||||
| Interest expense | |||||
| Total costs and expenses | |||||
| Income before income tax expense | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income per common share - basic | |||||
| Net income per common share - diluted | |||||
| Weighted average number of common stock - basic | |||||
| Weighted average number of common stock - diluted | |||||
Loading...